Form 8-K - Current report:
SEC Accession No. 0000310158-21-000015
Filing Date
2021-05-27
Accepted
2021-05-27 10:13:32
Documents
13
Period of Report
2021-05-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mrk-20210525.htm   iXBRL 8-K 79885
  Complete submission text file 0000310158-21-000015.txt   286596

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrk-20210525.xsd EX-101.SCH 3538
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrk-20210525_def.xml EX-101.DEF 17008
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrk-20210525_lab.xml EX-101.LAB 34474
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrk-20210525_pre.xml EX-101.PRE 17811
6 EXTRACTED XBRL INSTANCE DOCUMENT mrk-20210525_htm.xml XML 20877
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 21969242
SIC: 2834 Pharmaceutical Preparations